Literature DB >> 24907404

Inflammation and inflammatory control in interstitial cystitis/bladder pain syndrome: Associations with painful symptoms.

Andrew Schrepf1, Michael O'Donnell, Yi Luo, Catherine S Bradley, Karl Kreder, Susan Lutgendorf.   

Abstract

Toll-like receptors (TLR) are known to play a role in chronic pain, from animal models and limited research in humans, but their role in interstitial cystitis/bladder pain syndrome (IC/BPS) is unknown. Similarly, alterations of the hypothalamic-pituitary-adrenal axis have been reported in some pain conditions. Our objectives were to identify inflammatory processes that might distinguish individuals with IC/BPS from healthy controls (HC) and to examine their associations with IC/BPS symptoms. Female participants (58IC/BPS patients and 28HCs) completed pain and urinary symptom questionnaires and collected saliva for cortisol as part of the Multidisciplinary Approach to Pelvic Pain study. Inflammatory cytokines were assayed in plasma, and in TLR-2- and TLR-4-stimulated peripheral blood mononuclear cells. Controlling for BMI and negative affect, between-group differences were analyzed by general linear models, and relationships between symptoms and inflammatory variables were analyzed by regression. Compared to HCs, IC/BPS patients had higher levels of plasma interleukin-6 (P=.040), greater interleukin-1β responsive to TLR-2 stimulation (P=.040), and flatter diurnal cortisol slopes (P=.010), indicating inflammatory dysregulation. In IC/BPS patients, inflammation after TLR-4 stimulation was associated with multiple symptoms, including genitourinary pain (P=.010), sexual pain (P=.002), and marginally with urinary symptoms (P=.068). Genitourinary pain severity (P=.008), frequency (P=.001), and pain with intercourse (P=.002) were strongly associated with TLR-4 inflammatory response. TLR-4 appears to play a central role in painful symptoms of IC/BPS patients, which may be linked to poor endogenous inflammatory control. These findings may help to identify new mechanisms in IC/BPS and lead to new therapeutic approaches.
Copyright © 2014 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bladder pain syndrome; Hypothalamic–pituitary–adrenal axis; Inflammation; Interstitial cystitis; Pelvic pain; Toll-like receptors

Mesh:

Substances:

Year:  2014        PMID: 24907404      PMCID: PMC4166494          DOI: 10.1016/j.pain.2014.05.029

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  30 in total

1.  The negative effect of urologic chronic pelvic pain syndrome on female sexual function: a systematic review and meta-analysis.

Authors:  Yupeng Guan; Gang Yu; Guoren Wang; Zhiming Bai
Journal:  Int Urogynecol J       Date:  2019-06-21       Impact factor: 2.894

2.  Identification of novel non-invasive biomarkers of urinary chronic pelvic pain syndrome: findings from the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network.

Authors:  Adelle Dagher; Adam Curatolo; Monisha Sachdev; Alisa J Stephens; Chris Mullins; J Richard Landis; Adrie van Bokhoven; Andrew El-Hayek; John W Froehlich; Andrew C Briscoe; Roopali Roy; Jiang Yang; Michel A Pontari; David Zurakowski; Richard S Lee; Marsha A Moses
Journal:  BJU Int       Date:  2017-04-11       Impact factor: 5.588

3.  Adverse Childhood Experiences and Symptoms of Urologic Chronic Pelvic Pain Syndrome: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Study.

Authors:  Andrew Schrepf; Bruce Naliboff; David A Williams; Alisa J Stephens-Shields; J Richard Landis; Arpana Gupta; Emeran Mayer; Larissa V Rodriguez; Henry Lai; Yi Luo; Catherine Bradley; Karl Kreder; Susan K Lutgendorf
Journal:  Ann Behav Med       Date:  2018-09-13

Review 4.  Urologic chronic pelvic pain syndrome: insights from the MAPP Research Network.

Authors:  J Quentin Clemens; Chris Mullins; A Lenore Ackerman; Tamara Bavendam; Adrie van Bokhoven; Benjamin M Ellingson; Steven E Harte; Jason J Kutch; H Henry Lai; Katherine T Martucci; Robert Moldwin; Bruce D Naliboff; Michel A Pontari; Siobhan Sutcliffe; J Richard Landis
Journal:  Nat Rev Urol       Date:  2019-03       Impact factor: 14.432

Review 5.  Inflammasomes in the urinary tract: a disease-based review.

Authors:  J Todd Purves; F Monty Hughes
Journal:  Am J Physiol Renal Physiol       Date:  2016-05-11

6.  Sex-, Stress-, and Sympathetic Post-Ganglionic Neuron-Dependent Changes in the Expression of Pro- and Anti-Inflammatory Mediators in Rat Dural Immune Cells.

Authors:  Lisa A McIlvried; Lisa A Borghesi; Michael S Gold
Journal:  Headache       Date:  2015-06-30       Impact factor: 5.887

7.  Attenuation of cystitis and pain sensation in mice lacking fatty acid amide hydrolase.

Authors:  Zun-Yi Wang; Peiqing Wang; Cecilia J Hillard; Dale E Bjorling
Journal:  J Mol Neurosci       Date:  2014-11-06       Impact factor: 3.444

8.  Cystitis-induced bladder pain is Toll-like receptor 4 dependent in a transgenic autoimmune cystitis murine model: a MAPP Research Network animal study.

Authors:  Xiangrong Cui; Xuan Jing; Susan K Lutgendorf; Catherine S Bradley; Andrew Schrepf; Bradley A Erickson; Vincent A Magnotta; Timothy J Ness; Karl J Kreder; Michael A O'Donnell; Yi Luo
Journal:  Am J Physiol Renal Physiol       Date:  2019-05-15

9.  Inflammation and Symptom Change in Interstitial Cystitis or Bladder Pain Syndrome: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Study.

Authors:  Andrew Schrepf; Michael A O'Donnell; Yi Luo; Catherine S Bradley; Karl J Kreder; Susan K Lutgendorf
Journal:  Urology       Date:  2016-01-06       Impact factor: 2.649

10.  Gender-Based Violence, Physiological Stress, and Inflammation: A Cross-Sectional Study.

Authors:  Madeleine Heller; Sarah T Roberts; Linnet Masese; Jacquiline Ngina; Neha Chohan; Vrasha Chohan; Juma Shafi; R Scott McClelland; Eleanor Brindle; Susan M Graham
Journal:  J Womens Health (Larchmt)       Date:  2018-04-09       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.